Drug · DIN 02282135
APO-RISPERIDONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 5, 2006; first marketed July 5, 2006.
- Drug Identification Number (DIN)
- 02282135
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 1.0 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 5, 2006: NOC 8111Abbreviated New Drug Submission (ANDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “apo-risperidone”. A notice may cover another product or only some lots: read it to see what it covers.
- Apo-Risperidone (2015-10-06)October 6, 2015 · Drugs · Product safety · Type III
- APO-Risperidone (2015-06-03)June 4, 2015 · Drugs · Product safety · Type III
- APO-Risperidone (2015-04-28)May 7, 2015 · Drugs · Product safety · Type III
- Apo-Risperidone (2014-05-12)May 22, 2014 · Drugs · Product safety · Type III
Other DINs named APO-RISPERIDONE
- DIN 02282119 · Marketed
- DIN 02282127 · Marketed
- DIN 02282143 · Marketed
- DIN 02282151 · Marketed
- DIN 02282178 · Marketed
- DIN 02280396 · Dormant